Where is the finish line for endoscopic eradication therapy in Barrett ’s esophagus?

Endoscopic eradication therapy (EET) is performed with the central premise that replacing neoplastic Barrett ’s esophagus (BE) with neosquamous epithelium will result in a decreased risk of death of esophageal adenocarcinoma (EAC). Although level 1 data demonstrating decreased cancer death after EET are not available, we do have strong evidence that EET can decrease the incidence of EAC,1,2 both in patie nts with BE and low-grade dysplasia (LGD) and in those with BE and high-grade dysplasia (HGD).
Source: Gastrointestinal Endoscopy - Category: Gastroenterology Authors: Tags: Systematic review and meta-analysis Source Type: research